Chris Mirabile
Chris Mirabile
Serial Entrepreneur
Chris Mirabile is Founder & CEO of NOVOS, a human longevity company. Chris graduated from NYU’s Stern School of Business and later won their business plan competition with his startup company, Hotlist, a location-based social network that scaled to 220 million people’s social plans.
Kris Verburgh
Kris Verburgh
Medical Doctor
Dr. Kris Verburgh is a medical doctor and an expert in aging and longevity, and in new developments in medicine and biotechnology. He is a researcher at the Free University of Brussels, and faculty member at Singularity University Benelux, where he teaches about the future of medicine and longevity.
Daniel Ives
Daniel Ives
Biotechnologist
At Shift Bioscience, Daniel is making drugs for safer cellular rejuvenation in humans through the application of machine-learning 'driver' clocks to cellular reprogramming. Daniel is also a founding fellow of the OnDeck Longevity Biotech fellowship, a continuous community for people to come together to build, join, or invest in revolutionary longevity biotechnology startups.
Gordan Lauc
Gordan Lauc
Professor of Biochemistry and Molecular Biology
Dr. Gordan Lauc is the Professor of Biochemistry and Molecular Biology at the University of Zagreb, Director of the National Centre of Scientific Excellence in Personalised Healthcare, honorary professor at the University of Edinburgh and the Kings College London, and member of the Johns Hopkins Society of Scholars. In 2017 he initiated the launch of the Human Glycome project and is one of its two co-directors.
Sebastian A. Brunemeier
Sebastian A. Brunemeier
Biotechnician
Sebastian A. Brunemeier is a biotech founder and VC investor. He is CEO and Co-Founder of ImmuneAGE Pharma, a stealth-mode company developing small molecules for immune rejuvenation. Previously, he was Co-Founder and Chief Investment Officer at Cambrian Biopharma and a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world.
Michael Geer
Michael Geer
Healthspans Increaser
After mass consumer success building the largest dating site (Badoo) and consumer VPN (AnchorFree) in the world, Michael, motivated by seeing family members encounter tragic health outcomes, joined forces with his Co-Founder Peter Ward to collaborate with longevity scientists to bring predictive health monitoring and longevity interventions directly to consumers to increase their healthspans. Their service Humanity is currently in private testing with thousands on the waiting list to join.
Hannah Went
Hannah Went
Biologist
Hannah Went attended the University of Kentucky and graduated with a degree in Biology. During that time, she had multiple research internships at the University of Kentucky studying cell signaling and cell biology. After graduation, she worked for the International Peptide Society as their Director of Content and Research.
Reason
Reason
Biotechnologist
Long-time advocate for rejuvenation biotechnology and director of the aging research website Fight Aging. Reason is also the founder of Repair Biotechnologies,  a new venture that will focus on the development of gene therapies relevant to human rejuvenation.
Tobias Reichmuth
Tobias Reichmuth
Company Builder
Dr. Reichmuth has been building companies since he was 21 years old. He exited his first start-up in 2003, thereafter building Europe’s leading climate change infrastructure fund SUSI Partners, co-founded Crypto Finance Group and The Singularity Group and has invested in more than 20 start-ups. In 2020, he has launched the Longevity Investors Conference together with Marc P. Bernegger.
Peter Fedichev
Peter Fedichev
Biotech Entrepreneu
Peter Fedichev is a scientist and biotech entrepreneur. His scientific background lies in the field of condensed matter physics, biophysics and bioinformatics. Peter earned M.S. in theoretical physics from the Moscow Institute of Physics and Technology and Ph.D. from the University of Amsterdam.
Longevity Lyfe Mastermind
Longevity Lyfe Mastermind
Event Search